Annual

Prospect Capital Announces Annual Meeting Update

Retrieved on: 
Friday, December 2, 2022

NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (Prospect, our, or we) today announce that it held its annual meeting of stockholders (the Annual Meeting) on December 2, 2022.

Key Points: 
  • NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (Prospect, our, or we) today announce that it held its annual meeting of stockholders (the Annual Meeting) on December 2, 2022.
  • The proposals that were considered at the Annual Meeting are described in detail in the Companys definitive proxy statement for the Annual Meeting as filed with the Securities and Exchange Commission on September 13, 2022 (the Proxy).
  • Each share of common stock is entitled to one vote on each matter to be voted on by holders of the common stock at the Annual Meeting, and each share of preferred stock is entitled to one vote on each matter to be voted on by holders of the preferred stock at the Annual Meeting.
  • Prospect Capital Corporation (www.prospectstreet.com) is a business development company that focuses on lending to and investing in private businesses.

Royal KPN N.V.: Press Release: KPN nominates Ben Noteboom to Supervisory Board

Retrieved on: 
Friday, December 2, 2022

KPNs Supervisory Board is pleased to announce the nomination of Mr Ben Noteboom for appointment to the Supervisory Board as of the Annual General Meeting (AGM) in 2023.

Key Points: 
  • KPNs Supervisory Board is pleased to announce the nomination of Mr Ben Noteboom for appointment to the Supervisory Board as of the Annual General Meeting (AGM) in 2023.
  • He will succeed Mr Peter Hartman who will step down at the end of his second and final term as member of KPNs Supervisory Board.
  • Mr Noteboom is currently chairman of the supervisory board of Vopak, member of the supervisory board at Aegon and member of the Board of Cancer Center Amsterdam.
  • He previously served on supervisory boards of Ahold Delhaize, Wolters Kluwer and Corporate Express.

Direct Communication Solutions Announces Q3 Financials and Strong Revenue Growth

Retrieved on: 
Thursday, December 1, 2022

For the quarter ending September 30, 2022, ("Q3 2022") revenues were USD $4.7 million, versus USD $2.8 million in Q3 2021 (September 30, 2021) representing an increase of 68%.

Key Points: 
  • For the quarter ending September 30, 2022, ("Q3 2022") revenues were USD $4.7 million, versus USD $2.8 million in Q3 2021 (September 30, 2021) representing an increase of 68%.
  • For the quarter ending September 30, 2022, ("Q3 2022") gross profit was USD $1.2 million, versus USD $0.8 million in Q3 2021 (September 30, 2021) representing an increase of 50%.
  • The nine months gross profit ending Q3 2022, was reported at USD $5.7 million versus USD $3 million in 2021 representing an increase of 90%.
  • The nine months Adjusted EBITDA ending Q3 2022 was reported at USD $1.6 million versus a loss of USD $1.4 million in 2021, representing an increase of USD $3.0 million.

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Fourth Quarter Common Stock Distribution of $0.1276 Per Share

Retrieved on: 
Thursday, December 1, 2022

Annual NAV Total Return is the percentage change in the Funds NAV over a year, assuming reinvestment of distributions paid.

Key Points: 
  • Annual NAV Total Return is the percentage change in the Funds NAV over a year, assuming reinvestment of distributions paid.
  • 2 The annualized Current Distribution Rate is the current fiscal periods distribution rate annualized as a percentage of the Funds NAV as of November 30, 2022.
  • 3 Cumulative Total Return is the percentage change in the Funds NAV from December 31, 2021 to November 30, 2022, assuming reinvestment of distributions paid.
  • Sprott Focus Trust, Inc. is a closed-end diversified management investment company whose shares of Common Stock are listed and traded on the Nasdaq Global Select Market.

Allarity Therapeutics Reschedules 2022 Annual Stockholders Meeting and Sets New Record Date

Retrieved on: 
Thursday, December 1, 2022

Boston, MA U.S.A. (December 1, 2022) Allarity Therapeutics, Inc. (Allarity or the Company), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP companion diagnostics for personalized cancer care, today announced that the Companys adjourned 2022 Annual Stockholders Meeting (2022 ASM) set for December 2, 2022 has been cancelled and a new meeting date for the Annual Stockholders Meeting (2023 ASM) will be held, as a virtual meeting, on January 19, 2023.

Key Points: 
  • Boston, MA U.S.A. (December 1, 2022) Allarity Therapeutics, Inc. (Allarity or the Company), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP companion diagnostics for personalized cancer care, today announced that the Companys adjourned 2022 Annual Stockholders Meeting (2022 ASM) set for December 2, 2022 has been cancelled and a new meeting date for the Annual Stockholders Meeting (2023 ASM) will be held, as a virtual meeting, on January 19, 2023.
  • The annual meeting was rescheduled to January 19, 2023 in light of the new proposals to be considered at the annual meeting.
  • Stockholders of record as of December 6, 2022, will be entitled to notice of, and to vote at, the 2023 ASM.
  • The Company, however, reserves the right to change the record date prior to the 2023 ASM.

ISHLT Elects New Board Members and Professional Community Leaders

Retrieved on: 
Thursday, December 1, 2022

Professor Christian Benden, MD, MBA, FCCP, will serve as ISHLT President-Elect beginning in May 2023 and as ISHLT President beginning in May 2024.

Key Points: 
  • Professor Christian Benden, MD, MBA, FCCP, will serve as ISHLT President-Elect beginning in May 2023 and as ISHLT President beginning in May 2024.
  • "These results represent the development of coordinated election processes and were boosted by a record number of nominations and engagement of professional communities to expand opportunities for leadership in ISHLT to our members.
  • I am also pleased to see ISHLT leaders from five different countries elected to the ISHLT Board of Directors, and to see such a mix of geographical, gender, and generational representation stepping into leadership roles in the Professional Communities."
  • Beginning 1 May, 2023, the new composition of the Board will be:
    Director:Marc de Perrot, MD, Thoracic and Lung Transplant Surgeon, Canada (2024)
    The elected Professional Community leaders are:

ACF Equity Research signs My Language Connection as Official Language Partner

Retrieved on: 
Thursday, December 1, 2022

London, United Kingdom, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Global Research House ACF Equity Research (ACF) today announced My Language Connection (MLC) as its official language partner.

Key Points: 
  • London, United Kingdom, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Global Research House ACF Equity Research (ACF) today announced My Language Connection (MLC) as its official language partner.
  • Investment research is continually evolving, says Christopher Nicholson, Managing Director and Head of Research at ACF Equity Research.
  • My Language Connection is an ISO 17100 & 90012015 accredited translation agency , specialising in language services for a range of technical industries.
  • ACF Equity Research is an independent investment research company specialising in the highest specification independent equity research for corporate clients, which is then distributed globally and is free to investors.

BrandywineGLOBAL - Global Income Opportunities Fund Inc. (BWG or “the Fund”; CUSIP: 10537L104) Announces Notification of Sources of Distributions

Retrieved on: 
Thursday, December 1, 2022

Annual NAV Total Return is the percentage change in the Funds NAV over a year, assuming reinvestment of distributions paid.

Key Points: 
  • Annual NAV Total Return is the percentage change in the Funds NAV over a year, assuming reinvestment of distributions paid.
  • The Annualized Distribution Rate is the current fiscal periods distribution rate annualized as a percentage of the Funds NAV as of October 31, 2022.
  • Cumulative Total Return is the percentage change in the Funds NAV from October 31, 2021 through October 31, 2022, assuming reinvestment of distributions paid.
  • For further information on BrandywineGLOBAL - Global Income Opportunities Fund Inc.,
    please visit our web site at: www.franklintempleton.com/investments/options/closed-end-funds
    Data and commentary provided in this press release are for informational purposes only.

Western Asset Emerging Markets Debt Fund Inc. (EMD or “the Fund”; CUSIP: 95766A101) Announces Notification of Sources of Distributions

Retrieved on: 
Thursday, December 1, 2022

Annual NAV Total Return is the percentage change in the Funds NAV over a year, assuming reinvestment of distributions paid.

Key Points: 
  • Annual NAV Total Return is the percentage change in the Funds NAV over a year, assuming reinvestment of distributions paid.
  • The Annualized Distribution Rate is the current fiscal periods distribution rate annualized as a percentage of the Funds NAV as of October 31, 2022.
  • Cumulative Total Return is the percentage change in the Funds NAV from December 31, 2021 through October 31, 2022, assuming reinvestment of distributions paid.
  • For further information on Western Asset Emerging Markets Debt Fund Inc., please visit our web site at: www.franklintempleton.com/investments/options/closed-end-funds
    Data and commentary provided in this press release are for informational purposes only.

EQS-News: Wolford AG: Management Board welcomes resolved capital increase

Retrieved on: 
Thursday, December 1, 2022

Bregenz, December 1, 2022: The Extraordinary General Meeting of Wolford AG today voted in favor of a capital reduction and a subsequent capital increase.

Key Points: 
  • Bregenz, December 1, 2022: The Extraordinary General Meeting of Wolford AG today voted in favor of a capital reduction and a subsequent capital increase.
  • The capital increase is to be implemented in the first quarter of 2023.
  • Upon implementation of the capital increase, the Company will receive up to 20,157,450.00 euros.
  • "Wolford AG will receive up to EUR 20.2 million as part of these capital measures, which will increase the equity ratio to around 10 percent.